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The previous studies [l-4] have provided the 
basic data on a biochemical disorder in the central 
nervous system (CNS) of “Jimpy” mouse, a neurolo- 
gical mutant characterized by a severe myelin defi- 
ciency. The most marked feature of “Jimpy” brain 
was a striking reduction of cerebrosides and sulfa- 
tides. It was suggested that a disturbance of galacto- 
lipid synthesis may be the primary cause of cerebro- 
side and sulphatide reduction leading to a defective 
myelin formation [2,3]. 
Experiments conducted in vitro [S-7] with 
brain tissue indicated that UDP-galactose is the pre- 
cursor of the galactose moiety of cerebrosides, and 
that cerebrosides are formed from sphingosine via 
psychosine. Although the findings suggesting that 
cerebrosides may be formed directly from ceramide 
have been reported [8], psychosine seems to be 
more likely precursor. 
The study described in this communication was 
undertaken in order to elucidate whether the psycho- 
sine pathway is involved in the metabolic error of 
“Jimpy” mice. The results presented show that the 
incorporation of radioactivity into psychosine fol- 
lowing incubation of UDP-galactose-14C and sphingo 
sine with brain homogenate is significantly decreased 
in “Jimpy” brain. 
UDP-galactose-14C (uniformly labelled in the galac- 
tose moiety) was obtained from New England Nuclear 
Corp. (Boston). Natural sphingosine was prepared by 
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hydrolysis of rat brain sphingolipids [9] and purified 
by silicic acid column chromatography. Psychosine was 
obtained after hydrolysis of rat brain cerebrosides [lo] 
and purified by silicic acid column chromatography. 
The freshly removed brains of 1 ‘)-day-old “Jimpy” 
mice and the corresponding normal phenotypes were 
homogenized with 9 vol of cold 0.075 M Tris buffer 
containing 0.5 mM EDTA in a Potter-Elvehjem homc- 
genizer. An incubation system similar to that de- 
scribed by Cleland and Kennedy [6] was used. La- 
belled products were identified by co-chromatography 
with carrier lipids with several solvent systems. As it 
is shown in fig. 1, after 60 min of incubation virtually 
all of the radioactivity detected was associated with 
the fraction corresponding to psychosine (91 and 
96% in normal and “Jimpy” mice, respectively). In 
a considerably wide range (from l-3 mg of protein), 
psychosine formation was proportional to the homo- 
genate concentration (fig. 2). With normal brain homo- 
genates the synthesis of psychosine was 5-8 times 
as high as that observed with “Jimpy” homogenates. 
The possibility that an inhibitor is present was 
examined by the following experiment. To a complete 
incubation mixture containing 0.15 ml of normal 
brain homogenate, 0.15 ml of “Jimpy” homogenate 
was added. No decrease of enzymatic activity was ob- 
served as shown in table 1. 
These findings, in addition to those previously 
reported [2,3], support the statement that low cere- 
broside and sulphatide levels in mutant brain may 
result from an impairment of the galactolipid syn- 
thesis and may be interpreted as an evidence for the 
possibility that the metabolic error is located in the 
stage at which psychosine is formed. If this is so, the 
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Fig. 1. Illustration of thin-layer chromatographic separation 
of radioactive lipids after incubation of UDP-galactose-14C 
with normal and “Jimpy” brain homogenates. The reaction 
mixture contained 0.05 ml of 0.01 M UDP-galactose-14C, 
0.1 PC per pmole; 0.025 ml of 0.1 M MgC12; 0.05 ml of a 
0.02 M solution of sphingosine in 2.5% Tween; 0.075 ml ’ 
of 0.075 M Tris; 0.3 ml of a 10% brain homogenate. Incuba- 
tion was 60 mm at 37’. Reaction was terminated with 5 ml 
of chloroform-methanol (2: 1, v/v) and carrier cerebrosides, 
sulphatides and psychosine were added, followed by 0.5 ml 
of H20. After mixing, the upper phase was discarded and 
the lower phase washed twice with 1 ml of chloroform- 
methanol-H20 (3:47:48, v/v/v). The lipids in the lower 
phase were chromatographed on plates (20 X 24 cm) 
covered with a layer (0.5 mm) of silica gel H + 10% of 
finely ground Florisil using a two-step development ech- 
nique [ 111. The plates were first developed to the level 7 
cm from the bottom with chloroform-acetone-pyridine-20% 
aq. ammonia-H20 (20: 30:60: 2: 2, v/v). The area of adsor- 
bent including phospholipids (a 2.5-cm band starting at the 
bottom of the plate) was removed and chromatogram de- 
veloped with chloroform-acetone-methanol-H20 (65:30: 
12: 2) to the top of the plate. Spots were revealed with 
2’,7’-dichlorofluorescein, scraped into counting vials and 
radioactivity determined by liquid scintillation techniques. 
Identification of fractions: NL, neutral lipids; SP, sphingo- 
sine; CER, cerebrosides; SUL, sulphatides; PSY, psychosine; 
PL, phospholipids. 0 = origine; SF1 = first solvent front; SF2 
= second solvent front. 
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Fig. 2. Incubation of UDP-galactose-14C with normal and 
“Jimpy” brain homogenates: formation of psychosine as a 
function of enzyme concentration. The incubation system 
was similar to that described in fg. 1. Each point is the 
average of data from two or three experiments. Vertical 
bars represent he range of values. 
Table 1 
Effect of “Jimpy” homogenate addition on the enzyme acti- 
vity in normal brain 
Brain homogenate in the 
incubation mixture * 
Normal 
(ml) 
JUMPY 
(ml) 
Psychosine formed 
(cpm) 
0.15 0.15 202 
0.15 - 137 
0.15 37 
* Other conditions for incubation and assay of radioactivity 
were those described in fg 1. 
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results presented above are consistent with the view 
that the inborn metabolic defect of “Jimpy” mice 
may be related to the reduced activity of an enzyme 
(galactosyl-sphingosine transferase) catalyzing the 
formation of psychosine. The presence of this en- 
zyme has been reported in guinea-pig and rat brain 
microsomes [6]. 
In this connection, it is of interest to note that 
in “Quaking” mouse, another myelin deficient mu- 
tant with similar biochemical and histological char- 
acteristics [ 1, 121, our preliminary results revealed 
a markedly lowered activity of psychosine forma- 
tion. 
Further studies are necessary to find if the results 
presented in this paper may be related to the histo- 
chemical observations [ 131, suggesting a serious alter- 
ation of the glial cells which are essential for myelina- 
tion of CNS. 
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